Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I dose-escalation study of Fluorapacin Injection in patients with advanced solid tumors
ChiCTR-TNRC-09000561Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluorapacin in Nonhematologic neoplasms (5 cohorts), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Steady-state plasma pharmacokinetic parameters of Fluorapacin Injection, Safety and tolerability and 6 more. Started Jun 2009; status: completed.
02
Drugs
fluorapacin
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on ChiCTR-TNRC-09000561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-09000561.